Lymphoma News

Once cancer has reached this stage, it becomes very difficult for doctors to locate and treat the numerous tumors that can develop.

The plug has been pulled on a phase III randomized, open-label trial that was evaluating the safety and efficacy of the investigational compound inotuzumab ozogamicin in patients with relapsed or refractory CD22+ aggressive non-Hodgkin lymphoma who were not candidates for intensive high-dose chemotherapy.

Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a drug for aggressive non-Hodgkin lymphoma after independent monitors found it was not likely to improve survival.

By Kay S. Pedrotti Dinh Le, Lamar County high 2009 valedictorian and a popular figure among Barnesville's young people, has been diagnosed with Hodgkin's lymphoma and is taking chemotherapy at Emory Hospital.

Main Category: Lymphoma / Leukemia / Myeloma Also Included In: IT / Internet / E-mail ; Cancer / Oncology Article Date: 21 May 2013 - 1:00 PDT In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ... (more)

Claire E. Dearden, MD, Consultant Hematologist, Head of CLL Clinic, Royal Marsden Hospital, London, UK, highlights the pharmacotherapeutic strategies for the management of B- and T-cell PLL, noting the clinical outcomes associated with the diseases, and briefly touches on the future of PLL therapy.

's Federal Joint Committee has issued its final benefit assessment report for PIXUVRI , which is indicated as a monotherapy for the treatment of adult patients with aggressive B-cell non-Hodgkin lymphoma who have failed two or three prior lines of therapy.

The 66-year-old from Woolston is proof of just how crucial new discoveries and breakthroughs are to helping save lives, having taken part in a clinical trial that saw her receive pioneering treatment to beat the disease despite the odds being against her.

Students finish their activities Thursday morning by high-fiving members of the Field High School girls' soccer team.

AbbVie today announced that data evaluating several investigational compounds in the company's oncology pipeline will be presented at the upcoming 2013 American Society of Clinical Oncology Annual Meeting, May 31 - June 4, Chicago.

Premier League referee Mark Halsey retired on Sunday after taking charge of Norwich's 3-2 win at Manchester City on the final day of the season.

The United Food and Commercial Workers Local 12R24 and The Beer Store are joining forces in an effort to help find a cure for leukemia - the No.

Imaging scans following treatment for diffuse large B-cell lymphoma do little to help detect a relapse, a Mayo Clinic study has found.

On behalf of the Leukemia and Lymphoma Society, thank you to the generous people of the Ohio Valley for helping make the 13th-annual Ohio Valley Light the Night Walk a success.

About this sponsorship: In honor of the 60th anniversary of Sir Edmund Hillary's historic ascent of Mount Everest, Patch and Grape-Nuts are teaming up to highlight those who inspire people around them to climb their own mountains.

Friday, they surprised the 8th grader who is fighting cancer. The entire school had chipped in to buy him the surprise.

Team LaFontaine says it will host an '80s style fundraiser, 'The Nine and Wine,' to benefit the Leukemia & Lymphoma Society on Friday at Fountains Golf & Banquet.

During the trials, which involved 700 patients internationally, the drug was found to cut the risk of the cancer worsening by 86 per cent when combined with chemotherapy, compared with the risk when a patient had chemotherapy alone.

MICHAEL PATRICK/NEWS SENTINEL Maxine Odomirok visits the wig room at the American Cancer Society on May 9 looking for some scarves and turbans.

Michael Herlehy , one of Chicago's most ebullient ad people, passed away Monday at the age of 46 from complications related to a long battle with Hodgkin's disease.